GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dermapharm Holding SE (CHIX:DMPd) » Definitions » Degree of Operating Leverage

Dermapharm Holding SE (CHIX:DMPD) Degree of Operating Leverage : 10.79 (As of Dec. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Dermapharm Holding SE Degree of Operating Leverage?

Degree of Operating Leverage (DOL) measures the percentage change in EBIT for a unit change in Revenue. Dermapharm Holding SE's Degree of Operating Leverage for the quarter that ended in Dec. 2024 was 10.79. The higher Degree of Operating Leverage, the higher operating risk the company will take.

The industry rank for Dermapharm Holding SE's Degree of Operating Leverage or its related term are showing as below:

CHIX:DMPd's Degree of Operating Leverage is ranked worse than
88% of 942 companies
in the Drug Manufacturers industry
Industry Median: 0.87 vs CHIX:DMPd: 10.79

Dermapharm Holding SE Degree of Operating Leverage Historical Data

The historical data trend for Dermapharm Holding SE's Degree of Operating Leverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dermapharm Holding SE Degree of Operating Leverage Chart

Dermapharm Holding SE Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Degree of Operating Leverage
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.91 6.61 -2.79 -2.74 10.79

Dermapharm Holding SE Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Degree of Operating Leverage Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.74 -153.44 50.32 -24.89 10.79

Competitive Comparison of Dermapharm Holding SE's Degree of Operating Leverage

For the Drug Manufacturers - Specialty & Generic subindustry, Dermapharm Holding SE's Degree of Operating Leverage, along with its competitors' market caps and Degree of Operating Leverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dermapharm Holding SE's Degree of Operating Leverage Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Dermapharm Holding SE's Degree of Operating Leverage distribution charts can be found below:

* The bar in red indicates where Dermapharm Holding SE's Degree of Operating Leverage falls into.


;
;

Dermapharm Holding SE Degree of Operating Leverage Calculation

Dermapharm Holding SE's Degree of Operating Leverage for the quarter that ended in Dec. 2024 is calculated as:

Degree of Operating Leverage=% Change in EBIT**/% Change in Revenue
=( 230.413 (Dec. 2024) / 160.965 (Dec. 2023) - 1 )/( 1180.766 (Dec. 2024) / 1135.351 (Dec. 2023) - 1 )
=0.4314/0.04
=10.79***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** TTM data of EBIT and Revenue was used to calculate Degree of Operating Leverage.
*** Please be aware that the Degree of Operating Leverage calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


Dermapharm Holding SE  (CHIX:DMPd) Degree of Operating Leverage Explanation

Degree of Operating Leverage (DOL) is a leverage ratio that measures the sensitivity of a company’s operting income, also referred to as Earnings Before Interest and Taxes (EBIT), to fluctuations in its Revenue. DOL is a method used to quantify a company’s operating risk. This risk is related to the company's structure of variable costs and fixed costs. Since the fixed costs do not allow the company to adjust the operating costs, the operating risk rises with a higher fixed-to-variable costs proportion.

A high Degree of Operating Leverage indicates that the company’s fixed costs exceed its variable costs. By increasing the sales, the company can earn more profits. In addition, the company must be able to maintain relatively high sales to cover all fixed costs.

Be Aware

The use of operating leverage varies across different industries and business sectors, and the application of Degree of Operating Leverage (DOL) should be adjusted accordingly.


Dermapharm Holding SE Degree of Operating Leverage Related Terms

Thank you for viewing the detailed overview of Dermapharm Holding SE's Degree of Operating Leverage provided by GuruFocus.com. Please click on the following links to see related term pages.


Dermapharm Holding SE Business Description

Traded in Other Exchanges
Address
Lil-Dagover-Ring 7, Grunwald, BY, DEU, 82031
Dermapharm Holding SE manufactures patent-free branded pharmaceuticals for selected therapy fields, over-the-counter drugs, and natural remedies. The portfolio of the company includes cosmetics, nutritional supplements, and diet and medical devices. Business operating segments include Branded pharmaceuticals, which drive key revenue, Other healthcare products, and Parallel import business. The Branded pharmaceuticals segment covers numerous product areas through a wide variety of items sold under reputable brand names.

Dermapharm Holding SE Headlines

No Headlines